Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ominsky

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Regulatory Toxicology and Pharmacology : RTP|April 9, 2017
Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1-34)Jacquelin Jolette, Bassem Attalla, Aurore Varela, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 8, 2014
Adult Brtl/+ mouse model of osteogenesis imperfecta demonstrates anabolic response to sclerostin antibody treatment with increased bone mass and strengthB P Sinder, L E White, J D Salemi, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|May 1, 2014
Sclerostin monoclonal antibody enhanced bone fracture healing in an open osteotomy model in ratsPui Kit Suen, Yi-Xin He, Dick Ho Kiu Chow, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2007
Continuous RANKL inhibition in osteoprotegerin transgenic mice and rats suppresses bone resorption without impairing lymphorganogenesis or functional immune responsesMarina Stolina, Denise Dwyer, Michael S Ominsky, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 17, 2015
Sustained Modeling-Based Bone Formation During Adulthood in Cynomolgus Monkeys May Contribute to Continuous BMD Gains With DenosumabMichael S Ominsky, Cesar Libanati, Qing-Tian Niu, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 14, 2015
Transcriptional Profiling of Laser Capture Microdissected Subpopulations of the Osteoblast Lineage Provides Insight Into the Early Response to Sclerostin Antibody in RatsPaul Nioi, Scott Taylor, Rong Hu, et al.
Endocrinology|October 4, 2017
Sclerostin Blockade and Zoledronic Acid Improve Bone Mass and Strength in Male Mice With Exogenous HyperthyroidismElena Tsourdi, Franziska Lademann, Michael S Ominsky, et al.
The Journal of Bone and Joint Surgery. American Volume|November 20, 2015
Systemic Administration of Sclerostin Antibody Enhances Bone Morphogenetic Protein-Induced Femoral Defect Repair in a Rat ModelBrian A Tinsley, Alex Dukas, Michael J Pensak, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 29, 2014
Bone matrix quality after sclerostin antibody treatmentRyan D Ross, Lindsey H Edwards, Alvin S Acerbo, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 12, 2021
Early Effects of Abaloparatide on Bone Formation and Resorption Indices in Postmenopausal Women With OsteoporosisDavid W Dempster, Hua Zhou, Sudhaker D Rao, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Regulatory Toxicology and Pharmacology : RTP|April 9, 2017
Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1-34)Jacquelin Jolette, Bassem Attalla, Aurore Varela, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 8, 2014
Adult Brtl/+ mouse model of osteogenesis imperfecta demonstrates anabolic response to sclerostin antibody treatment with increased bone mass and strengthB P Sinder, L E White, J D Salemi, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|May 1, 2014
Sclerostin monoclonal antibody enhanced bone fracture healing in an open osteotomy model in ratsPui Kit Suen, Yi-Xin He, Dick Ho Kiu Chow, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2007
Continuous RANKL inhibition in osteoprotegerin transgenic mice and rats suppresses bone resorption without impairing lymphorganogenesis or functional immune responsesMarina Stolina, Denise Dwyer, Michael S Ominsky, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 17, 2015
Sustained Modeling-Based Bone Formation During Adulthood in Cynomolgus Monkeys May Contribute to Continuous BMD Gains With DenosumabMichael S Ominsky, Cesar Libanati, Qing-Tian Niu, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 14, 2015
Transcriptional Profiling of Laser Capture Microdissected Subpopulations of the Osteoblast Lineage Provides Insight Into the Early Response to Sclerostin Antibody in RatsPaul Nioi, Scott Taylor, Rong Hu, et al.
Endocrinology|October 4, 2017
Sclerostin Blockade and Zoledronic Acid Improve Bone Mass and Strength in Male Mice With Exogenous HyperthyroidismElena Tsourdi, Franziska Lademann, Michael S Ominsky, et al.
The Journal of Bone and Joint Surgery. American Volume|November 20, 2015
Systemic Administration of Sclerostin Antibody Enhances Bone Morphogenetic Protein-Induced Femoral Defect Repair in a Rat ModelBrian A Tinsley, Alex Dukas, Michael J Pensak, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 29, 2014
Bone matrix quality after sclerostin antibody treatmentRyan D Ross, Lindsey H Edwards, Alvin S Acerbo, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 12, 2021
Early Effects of Abaloparatide on Bone Formation and Resorption Indices in Postmenopausal Women With OsteoporosisDavid W Dempster, Hua Zhou, Sudhaker D Rao, et al.
Pageof 9